Literature DB >> 35928857

SARS-CoV-2: Novel Therapeutic Approaches for Diagnosis and Treatment.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2022        PMID： 35928857      PMCID： PMC9345379          DOI： 10.1021/acsmedchemlett.2c00231

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  6 in total

Review 1.  The state of the art of PROTAC technologies for drug discovery.

Authors:  Chao Wang; Cangxin Zheng; Han Wang; Liangren Zhang; Zhenming Liu; Ping Xu
Journal:  Eur J Med Chem       Date:  2022-03-15       Impact factor: 6.514

Review 2.  Inhibition of SARS-CoV-2 by Targeting Conserved Viral RNA Structures and Sequences.

Authors:  Shalakha Hegde; Zhichao Tang; Junxing Zhao; Jingxin Wang
Journal:  Front Chem       Date:  2021-12-23       Impact factor: 5.221

Review 3.  A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson.

Authors:  Rikin Patel; Mohamad Kaki; Venkat S Potluri; Payal Kahar; Deepesh Khanna
Journal:  Hum Vaccin Immunother       Date:  2022-02-07       Impact factor: 3.452

Review 4.  Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary.

Authors:  Shujing Xu; Dang Ding; Xujie Zhang; Lin Sun; Dongwei Kang; Boshi Huang; Xinyong Liu; Peng Zhan
Journal:  Molecules       Date:  2022-01-27       Impact factor: 4.411

Review 5.  2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update.

Authors:  Zoufang Huang; Vivek P Chavda; Lalitkumar K Vora; Normi Gajjar; Vasso Apostolopoulos; Nirav Shah; Zhe-Sheng Chen
Journal:  Front Pharmacol       Date:  2022-04-12       Impact factor: 5.988

Review 6.  PROTAC targeted protein degraders: the past is prologue.

Authors:  Miklós Békés; David R Langley; Craig M Crews
Journal:  Nat Rev Drug Discov       Date:  2022-01-18       Impact factor: 112.288
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.